Bacterial, fungal and protozoan carbonic anhydrases as drug targets

Expert Opinion on Therapeutic Targets

Volumn 19, Issue 12, 2015, Pages 1689-1704

  Capasso, Clemente ^a   Supuran, Claudiu T ^b  

^a CNR   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

antiinfective; bacteria; carbonic anhydrases; fungi; hydroxamate; inhibitors; pathogens; protozoa; sulfonamide; thiols; X ray

Indexed keywords

ALPHA CARBONATE DEHYDRATASE; BETA CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE INHIBITOR; DITHIOCARBAMIC ACID; ETA CARBONATE DEHYDRATASE; GAMMA CARBONATE DEHYDRATASE; PHENOL DERIVATIVE; SULFONAMIDE; THIOL REAGENT; UNCLASSIFIED DRUG; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIPROTOZOAL AGENT;

BACTERIAL GROWTH; BACTERIAL VIRULENCE; BRUCELLA SUIS; CANDIDA ALBICANS; CRYPTOCOCCUS NEOFORMANS; DRUG TARGETING; FUNGUS GROWTH; HELICOBACTER PYLORI; LEISHMANIA CHAGASI; MALASSEZIA GLOBOSA; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENICITY; PLASMODIUM FALCIPARUM; REVIEW; TRYPANOSOMA CRUZI; ANIMAL; BACTERIAL INFECTIONS; DRUG DESIGN; DRUG EFFECTS; ENZYMOLOGY; HUMAN; METABOLISM; MICROBIOLOGY; MOLECULARLY TARGETED THERAPY; MYCOSES; PROTOZOAN INFECTIONS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ANTIPROTOZOAL AGENTS; BACTERIAL INFECTIONS; CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; DRUG DESIGN; HUMANS; MOLECULAR TARGETED THERAPY; MYCOSES; PROTOZOAN INFECTIONS;

EID: 84952874486     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2015.1067685     Document Type: Review

References (165)

1. Tibayrenc M, Ayala FJ. Reproductive clonality of pathogens: A perspective on pathogenic viruses, bacteria, fungi, and parasitic protozoa. Proc Natl Acad Sci USA 2012;109:E3305-13
2. Roux O, Cereghino R, Solano PJ, et al. Caterpillars and fungal pathogens: two co-occurring parasites of an ant-plant mutualism. PLoS One 2011;6:e20538
3. Joyce SA, Watson RJ, Clarke DJ. The regulation of pathogenicity and mutualism in Photorhabdus. Curr Opin Microbiol 2006;9:127-32
4. Soto W, Punke EB, Nishiguchi MK. Evolutionary perspectives in a mutualism of sepiolid squid and bioluminescent bacteria: combined usage of microbial experimental evolution and temporal population genetics. Evolution 2012;66:1308-21
5. Cardoso T, Ribeiro O, Aragao IC, et al. Additional risk factors for infection by multidrug-resistant pathogens in healthcare-associated infection: a large cohort study. BMC Infect Dis 2012;12:375
6. Eiros Bouza JM, Oteo Revuelta JA. Zoonotic infectious diseases. Enferm Infecc Microbiol Clin 2011;29:51-4
7. Slingenbergh JI, Gilbert M, de Balogh KI, et al. Ecological sources of zoonotic diseases. Rev Sci Tech 2004;23:467-84
8. Cox GM, Mukherjee J, Cole GT, et al. Urease as a virulence factor in experimental cryptococcosis. Infect Immun 2000;68:443-8
9. Cox GM, McDade HC, Chen SC, et al. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol 2001;39:166-75
10. Bostanci N, Belibasakis GN. Porphyromonas gingivalis: an invasive and evasive opportunistic oral pathogen. FEMS Microbiol Lett 2012;333:1-9
11. Alp S. Putative virulence factors of Aspergillus species. Mikrobiyol Bul 2006;40:109-19
12. Schaller M, Borelli C, Korting HC, et al. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses 2005;48:365-77
13. Kronholm S, Capel P. Concentrations, loads, and yields of organic carbon in streams of agricultural watersheds. J Environ Qual 2012;41:1874-83
14. Wingate L, Ogee J, Cuntz M, et al. The impact of soil microorganisms on the global budget of delta18O in atmospheric CO2. Proc Natl Acad Sci USA 2009;106:22411-15
15. Freeman C, Kim SY, Lee SH, et al. Effects of elevated atmospheric CO2 concentrations on soil microorganisms. J Microbiol 2004;42:267-77
16. Johnson X, Alric J. Interaction between starch breakdown, acetate assimilation, and photosynthetic cyclic electron flow in Chlamydomonas reinhardtii. J Biol Chem 2012;287:26445-52
17. Tcherkez G, Boex-Fontvieille E, Mahe A, et al. Respiratory carbon fluxes in leaves. Curr Opin Plant Biol 2012;15:308-14
18. Casey JR. Why bicarbonate? Biochem Cell Biol 2006;84:930-9
19. Kozliak EI, Fuchs JA, Guilloton MB, et al. Role of bicarbonate/CO2 in the inhibition of Escherichia coli growth by cyanate. J Bacteriol 1995;177:3213-19
20. Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168-81
21. Supuran CT, Casini A, Scozzafava A. Protease inhibitors of the sulfonamide type: anticancer, antiinflammatory, and antiviral agents. Med Res Rev 2003;23:535-58
22. Alterio V, Di Fiore A, D'Ambrosio K, et al. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 2012;112:4421-68
23. Vullo D, Del Prete S, Osman SM, et al. Sulfonamide inhibition studies of the gamma-carbonic anhydrase from the oral pathogen Porphyromonas gingivalis. Bioorg Med Chem Lett 2014;24:240-4
24. Nishimori I, Vullo D, Minakuchi T, et al. Anion inhibition studies of two new beta-carbonic anhydrases from the bacterial pathogen Legionella pneumophila. Bioorg Med Chem Lett 2014;24:1127-32
25. Del Prete S, De Luca V, Scozzafava A, et al. Biochemical properties of a new alpha-carbonic anhydrase from the human pathogenic bacterium, Vibrio cholerae. J Enzyme Inhib Med Chem 2014;29:23-7
26. Alafeefy AM, Abdel-Aziz HA, Vullo D, et al. Inhibition of carbonic anhydrases from the extremophilic bacteria Sulfurihydrogenibium yellostonense (SspCA) and S. azorense (SazCA) with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4]triazolo[3,4-b] [1,3,4]thiadiazinyl-or 2- (cyanophenylmethylene)-1,3,4-thiadiazol-3 (2H)-yl moieties. Bioorg Med Chem 2014;22:141-7
27. Vullo D, Sai Kumar RS, Scozzafava A, et al. Anion inhibition studies of a betacarbonic anhydrase from Clostridium perfringens. Bioorg Med Chem Lett 2013;23:6706-10
28. Vullo D, De Luca V, Scozzafava A, et al. The extremo-alpha-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium azorense is highly inhibited by sulfonamides. Bioorg Med Chem 2013;21:4521-5
29. Luca VD, Vullo D, Scozzafava A, et al. An alpha-carbonic anhydrase from the thermophilic bacterium Sulphurihydrogenibium azorense is the fastest enzyme known for the CO2 hydration reaction. Bioorg Med Chem 2013;21:1465-9
30. Di Fiore A, Capasso C, De Luca V, et al. X-ray structure of the first 'extremo-alpha-carbonic anhydrase', a dimeric enzyme from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1. Acta Crystallogr D Biol Crystallogr 2013;69:1150-9
31. Del Prete S, Vullo D, De Luca V, et al. A highly catalytically active gammacarbonic anhydrase from the pathogenic anaerobe Porphyromonas gingivalis and its inhibition profile with anions and small molecules. Bioorg Med Chem Lett 2013;23:4067-71
32. Del Prete S, De Luca V, Vullo D, et al. Biochemical characterization of the gamma-carbonic anhydrase from the oral pathogen Porphyromonas gingivalis, PgiCA. J Enzyme Inhib Med Chem 2014;29(4):532-7
33. Vullo D, De Luca V, Scozzafava A, et al. The first activation study of a bacterial carbonic anhydrase (CA). The thermostable alpha-CA from Sulfurihydrogenibium yellowstonense YO3AOP1 is highly activated by amino acids and amines. Bioorg Med Chem Lett 2012;22:6324-7
34. Vullo D, De Luca V, Scozzafava A, et al. Anion inhibition studies of the fastest carbonic anhydrase (CA) known, the extremo-CA from the bacterium Sulfurihydrogenibium azorense. Bioorg Med Chem Lett 2012;22:7142-5
35. Del Prete S, Isik S, Vullo D, et al. DNA cloning, characterization, and inhibition studies of an alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J Med Chem 2012;55:10742-8
36. De Luca V, Vullo D, Scozzafava A, et al. Anion inhibition studies of an alpha-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1. Bioorg Med Chem Lett 2012;22:5630-4
37. Aksu K, Nar M, Tanc M, et al. Synthesis and carbonic anhydrase inhibitory properties of sulfamides structurally related to dopamine. Bioorg Med Chem 2013;21:2925-31
38. De Simone G, Alterio V, Supuran CT. Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors. Expert Opin Drug Discov 2013;8:793-810
39. Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012;27:759-72
40. Del Prete S, Vullo D, Fisher GM, et al. Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum-The eta-carbonic anhydrases. Bioorg Med Chem Lett 2014;24:4389-96
41. Vullo D, Del Prete S, Osman SM, et al. Sulfonamide inhibition studies of the delta-carbonic anhydrase from the diatom Thalassiosira weissflogii. Bioorg Med Chem Lett 2014;24:275-9
42. Del Prete S, Vullo D, Scozzafava A, et al. Cloning, characterization and anion inhibition study of the delta-class carbonic anhydrase (TweCA) from the marine diatom Thalassiosira weissflogii. Bioorg Med Chem 2014;22:531-7
43. Capasso C, Supuran CT. Anti-infective carbonic anhydrase inhibitors: a patent and literature review. Expert Opin Ther Pat 2013;23:693-704
44. Vullo D, Kupriyanova EV, Scozzafava A, et al. Anion inhibition study of the betacarbonic anhydrase (CahB1) from the cyanobacterium Coleofasciculus chthonoplastes (ex-Microcoleus chthonoplastes). Bioorg Med Chem 2014;22:1667-71
45. Vullo D, Flemetakis E, Scozzafava A, et al. Anion inhibition studies of two alpha-carbonic anhydrases from Lotus japonicus, LjCAA1 and LjCAA2. J Inorg Biochem 2014;136:67-72
46. Vullo D, Del Prete S, Osman SM, et al. Anion inhibition study of the beta-class carbonic anhydrase (PgiCAb) from the oral pathogen Porphyromonas gingivalis. Bioorg Med Chem Lett 2014;24:4402-6
47. Rodrigues GC, Feijo DF, Bozza MT, et al. Design, synthesis, and evaluation of hydroxamic acid derivatives as promising agents for the management of Chagas disease. J Med Chem 2014;57:298-308
48. Prete SD, Vullo D, Osman SM, et al. Sulfonamide inhibition study of the carbonic anhydrases from the bacterial pathogen Porphyromonas gingivalis: the beta-class (PgiCAb) versus the gammaclass (PgiCA) enzymes. Bioorg Med Chem 2014;22:4537-43
49. Nishimori I, Vullo D, Minakuchi T, et al. Sulfonamide inhibition studies of two beta-carbonic anhydrases from the bacterial pathogen Legionella pneumophila. Bioorg Med Chem 2014;22:2939-46
50. Migliardini F, De Luca V, Carginale V, et al. Biomimetic CO2 capture using a highly thermostable bacterial alphacarbonic anhydrase immobilized on a polyurethane foam. J Enzyme Inhib Med Chem 2014;29:146-50
51. Del Prete S, Vullo D, De Luca V, et al. Biochemical characterization of recombinant beta-carbonic anhydrase (PgiCAb) identified in the genome of the oral pathogenic bacterium Porphyromonas gingivalis. J Enzyme Inhib Med Chem 2014. [Epub ahead of print]
52. Del Prete S, De Luca V, Vullo D, et al. Biochemical characterization of the gamma-carbonic anhydrase from the oral pathogen Porphyromonas gingivalis, PgiCA. J Enzyme Inhib Med Chem 2014;29:532-7
53. Del Prete S, Vullo D, Fisher GM, et al. Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum-the eta-carbonic anhydrases. Bioorg Med Chem Lett 2014;24:4389-96
54. De Luca V, Del Prete S, Supuran CT, et al. Protonography, a new technique for the analysis of carbonic anhydrase activity. J Enzyme Inhib Med Chem 2015;30(2):277-82
55. Ceruso M, Del Prete S, AlOthman Z, et al. Synthesis of sulfonamides with effective inhibitory action against Porphyromonas gingivalis gammacarbonic anhydrase. Bioorg Med Chem Lett 2014;24:4006-10
56. Lehneck R, Neumann P, Vullo D, et al. Crystal structures of two tetrameric betacarbonic anhydrases from the filamentous ascomycete Sordaria macrospora. FEBS J 2014;281(7):1759-72
57. Di Fiore A, Truppo E, Supuran CT, et al. Crystal structure of the C183S/C217S mutant of human CA VII in complex with acetazolamide. Bioorg Med Chem Lett 2010;20:5023-6
58. Avvaru BS, Wagner JM, Maresca A, et al. Carbonic anhydrase inhibitors. The X-ray crystal structure of human isoform II in adduct with an adamantyl analogue of acetazolamide resides in a less utilized binding pocket than most hydrophobic inhibitors. Bioorg Med Chem Lett 2010;20:4376-81
59. Temperini C, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. X-ray crystal studies of the carbonic anhydrase II-trithiocarbonate adduct-an inhibitor mimicking the sulfonamide and urea binding to the enzyme. Bioorg Med Chem Lett 2010;20:474-8
60. Alterio V, Hilvo M, Di Fiore A, et al. Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX. Proc Natl Acad Sci USA 2009;106:16233-8
61. Di Fiore A, Monti SM, Hilvo M, et al. Crystal structure of human carbonic anhydrase XIII and its complex with the inhibitor acetazolamide. Proteins 2009;74:164-75
62. Temperini C, Scozzafava A, Puccetti L, et al. Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with L-histidine as a platform for the design of stronger activators. Bioorg Med Chem Lett 2005;15:5136-41
63. Guzel O, Innocenti A, Vullo D, et al. 3-phenyl-1H-indole-5-sulfonamides: structure-based drug design of a promising class of carbonic anhydrase inhibitors. Curr Pharm Des 2010;16:3317-26
64. Temperini C, Innocenti A, Guerri A, et al. Phosph(on)ate as a zinc-binding group in metalloenzyme inhibitors: X-ray crystal structure of the antiviral drug foscarnet complexed to human carbonic anhydrase I. Bioorg Med Chem Lett 2007;17:2210-15
65. Winum JY, Temperini C, El Cheikh K, et al. Carbonic anhydrase inhibitors: clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue. J Med Chem 2006;49:7024-31
66. De Simone G, Di Fiore A, Capasso C, et al. The zinc coordination pattern in the h-carbonic anhydrase from Plasmodium falciparum is different from all other carbonic anhydrase genetic families. Bioorg Med Chem Lett 2015;25:1385-9
67. Sacarlal J, Nhacolo AQ, Sigauque B, et al. A 10 year study of the cause of death in children under 15 years in Manhica, Mozambique. BMC Public Health 2009;9:67
68. Gaynor M, Mankin AS. Macrolide antibiotics: binding site, mechanism of action, resistance. Curr Top Med Chem 2003;3:949-61
69. Rusconi S, Scozzafava A, Mastrolorenzo A, et al. New advances in HIV entry inhibitors development. Curr Drug Targets Infect Disord 2004;4:339-55
70. Innocenti A, Hall RA, Schlicker C, et al. Carbonic anhydrase inhibitors. Inhibition and homology modeling studies of the fungal beta-carbonic anhydrase from Candida albicans with sulfonamides. Bioorg Med Chem 2009;17:4503-9
71. Maresca A, Scozzafava A, Kohler S, et al. Inhibition of beta-carbonic anhydrases from the bacterial pathogen Brucella suis with inorganic anions. J Inorg Biochem 2012;110:36-9
72. Supuran CT. Inhibition of bacterial carbonic anhydrases and zinc proteases: from orphan targets to innovative new antibiotic drugs. Curr Med Chem 2012;19:831-44
73. Bertucci A, Innocenti A, Scozzafava A, et al. Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata. Bioorg Med Chem Lett 2011;21:710-14
74. Supuran CT. Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2010;20:3467-74
75. Sulek K. [Nobel prize for Gerhard Domagk in 1939 for discovery of the antibacterial activity of prontosil]. Wiad Lek 1968;21:1089
76. Supuran CT. Bacterial carbonic anhydrases as drug targets: toward novel antibiotics? Front Pharmacol 2011;2:34
77. Vullo D, Nishimori I, Minakuchi T, et al. Inhibition studies with anions and small molecules of two novel betacarbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium. Bioorg Med Chem Lett 2011;21:3591-5
78. Del Prete S, Vullo D, Scozzafava A, et al. Cloning, characterization and anion inhibition study of the delta-class carbonic anhydrase (TweCA) from the marine diatom Thalassiosira weissflogii. Bioorg Med Chem 2014;22(1):531-7
79. Vullo D, Luca VD, Scozzafava A, et al. The alpha-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1 is highly susceptible to inhibition by sulfonamides. Bioorg Med Chem 2013;21(6):1534-8
80. Luca VD, Vullo D, Scozzafava A, et al. An alpha-carbonic anhydrase from the thermophilic bacterium Sulphurihydrogenibium azorense is the fastest enzyme known for the CO(2) hydration reaction. Bioorg Med Chem 2013;21(6):1465-9
81. Akdemir A, Vullo D, Luca VD, et al. The extremo-alpha-carbonic anhydrase (CA) from Sulfurihydrogenibium azorense, the fastest CA known, is highly activated by amino acids and amines. Bioorg Med Chem Lett 2013;23(4):1087-90
82. Carta F, Aggarwal M, Maresca A, et al. Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo. J Med Chem 2012;55:1721-30
83. Carta F, Aggarwal M, Maresca A, et al. Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations. Chem Commun (Camb) 2012;48:1868-70
84. Monti SM, Maresca A, Viparelli F, et al. Dithiocarbamates are strong inhibitors of the beta-class fungal carbonic anhydrases from Cryptococcus neoformans, Candida albicans and Candida glabrata. Bioorg Med Chem Lett 2012;22:859-62
85. Maresca A, Carta F, Vullo D, et al. Dithiocarbamates strongly inhibit the beta-class carbonic anhydrases from Mycobacterium tuberculosis. J Enzyme Inhib Med Chem 2013;28:407-11
86. Scozzafava A, Mastrolorenzo A, Supuran CT. Arylsulfonyl-N,N-dialkyldithiocarbamates as tumor cell growth inhibitors: novel agents targeting betatubulin? J Enzyme Inhib 2001;16:55-63
87. Scozzafava A, Mastrolorenzo A, Supuran CT. Arylsulfonyl-N,N-diethyldithiocarbamates: a novel class of antitumor agents. Bioorg Med Chem Lett 2000;10:1887-91
88. Innocenti A, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of transmembrane isoforms IX, XII, and XIV with less investigated anions including trithiocarbonate and dithiocarbamate. Bioorg Med Chem Lett 2010;20:1548-50
89. McKenna R, Supuran CT. Carbonic anhydrase inhibitors drug design. Subcell Biochem 2014;75:291-323
90. Adak AK, Leonov AP, Ding N, et al. Bishydrazide glycoconjugates for lectin recognition and capture of bacterial pathogens. Bioconjug Chem 2010;21:2065-75
91. Smith KS, Ferry JG. Prokaryotic carbonic anhydrases. FEMS Microbiol Rev 2000;24:335-66
92. Maeda S, Price GD, Badger MR, et al. Bicarbonate binding activity of the CmpA protein of the cyanobacterium Synechococcus sp. strain PCC 7942 involved in active transport of bicarbonate. J Biol Chem 2000;275:20551-5
93. Joseph P, Ouahrani-Bettache S, Montero JL, et al. A new beta-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth. Bioorg Med Chem 2011;19:1172-8
94. Joseph P, Turtaut F, Ouahrani-Bettache S, et al. Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Brucella suis. J Med Chem 2010;53:2277-85
95. Adler L, Brundell J, Falkbring SO, et al. Carbonic anhydrase from Neisseria sicca, strain 6021. I. Bacterial growth and purification of the enzyme. Biochim Biophys Acta 1972;284:298-310
96. Chirica LC, Elleby B, Jonsson BH, et al. The complete sequence, expression in Escherichia coli, purification and some properties of carbonic anhydrase from Neisseria gonorrhoeae. Eur J Biochem 1997;244:755-60
97. Chirica LC, Petersson C, Hurtig M, et al. Expression and localization of alpha- and beta-carbonic anhydrase in Helicobacter pylori. Biochim Biophys Acta 2002;1601:192-9
98. Guilloton MB, Korte JJ, Lamblin AF, et al. Carbonic anhydrase in Escherichia coli. A product of the cyn operon. J Biol Chem 1992;267:3731-4
99. Nishimori I, Minakuchi T, Morimoto K, et al. Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs. J Med Chem 2006;49:2117-26
100. Nishimori I, Onishi S, Takeuchi H, et al. The alpha and beta classes carbonic anhydrases from Helicobacter pylori as novel drug targets. Curr Pharm Des 2008;14:622-30
101. Shahidzadeh R, Opekun A, Shiotani A, et al. Effect of the carbonic anhydrase inhibitor, acetazolamide, on Helicobacter pylori infection in vivo: a pilot study. Helicobacter 2005;10:136-8
102. Nishimori I, Vullo D, Minakuchi T, et al. Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori. Bioorg Med Chem Lett 2006;16:2182-8
103. Nishimori I, Minakuchi T, Kohsaki T, et al. Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors. Bioorg Med Chem Lett 2007;17:3585-94
104. Morishita S, Nishimori I, Minakuchi T, et al. Cloning, polymorphism, and inhibition of beta-carbonic anhydrase of Helicobacter pylori. J Gastroenterol 2008;43:849-57
105. Vullo D, Isik S, Del Prete S, et al. Anion inhibition studies of the alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. Bioorg Med Chem Lett 2013;23:1636-8
106. Supuran CT. Carbonic anhydrase inhibition/activation: trip of a scientist around the world in the search of novel chemotypes and drug targets. Curr Pharm Des 2010;16:3233-45
107. Buchieri MV, Riafrecha LE, Rodriguez OM, et al. Inhibition of the beta-carbonic anhydrases from Mycobacterium tuberculosis with C-cinnamoyl glycosides: identification of the first inhibitor with anti-mycobacterial activity. Bioorg Med Chem Lett 2013;23:740-3
108. Burghout P, Vullo D, Scozzafava A, et al. Inhibition of the beta-carbonic anhydrase from Streptococcus pneumoniae by inorganic anions and small molecules: Toward innovative drug design of antiinfectives? Bioorg Med Chem 2011;19:243-8
109. Cronk JD, O'Neill JW, Cronk MR, et al. Cloning, crystallization and preliminary characterization of a betacarbonic anhydrase from Escherichia coli. Acta Crystallogr D Biol Crystallogr 2000;56:1176-9
110. Guzel O, Maresca A, Scozzafava A, et al. Discovery of low nanomolar and subnanomolar inhibitors of the mycobacterial beta-carbonic anhydrases Rv1284 and Rv3273. J Med Chem 2009;52:4063-7
111. Nishimori I, Minakuchi T, Maresca A, et al. The beta-carbonic anhydrases from Mycobacterium tuberculosis as drug targets. Curr Pharm Des 2010;16:3300-9
112. Nishimori I, Minakuchi T, Vullo D, et al. Inhibition studies of the betacarbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates. Bioorg Med Chem 2011;19:5023-30
113. Cronk JD, Rowlett RS, Zhang KY, et al. Identification of a novel noncatalytic bicarbonate binding site in eubacterial beta-carbonic anhydrase. Biochemistry 2006;45:4351-61
114. Suarez Covarrubias A, Larsson AM, Hogbom M, et al. Structure and function of carbonic anhydrases from Mycobacterium tuberculosis. J Biol Chem 2005;280:18782-9
115. Suarez M, Haenni M, Canarelli S, et al. Structure-function characterization and optimization of a plant-derived antibacterial peptide. Antimicrob Agents Chemother 2005;49:3847-57
116. Carta F, Maresca A, Covarrubias AS, et al. Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c. Bioorg Med Chem Lett 2009;19:6649-54
117. Minakuchi T, Nishimori I, Vullo D, et al. Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate. J Med Chem 2009;52:2226-32
118. Nishimori I, Minakuchi T, Onishi S, et al. Carbonic anhydrase inhibitors. Cloning, characterization and inhibition studies of the cytosolic isozyme III with anions. J Enzyme Inhib Med Chem 2009;24:70-6
119. Vullo D, Nishimori I, Scozzafava A, et al. Inhibition studies of a betacarbonic anhydrase from Brucella suis with a series of water soluble glycosyl sulfanilamides. Bioorg Med Chem Lett 2010;20:2178-82
120. Alber BE, Ferry JG. A carbonic anhydrase from the archaeon Methanosarcina thermophila. Proc Natl Acad Sci USA 1994;91:6909-13
121. Guzel O, Innocenti A, Hall RA, et al. Carbonic anhydrase inhibitors. The nematode alpha-carbonic anhydrase of Caenorhabditis elegans CAH-4b is highly inhibited by 2- (hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides. Bioorg Med Chem 2009;17:3212-15
122. Crocetti L, Maresca A, Temperini C, et al. A thiabendazole sulfonamide shows potent inhibitory activity against mammalian and nematode alphacarbonic anhydrases. Bioorg Med Chem Lett 2009;19:1371-5
123. Riafrecha LE, Vullo D, Supuran CT, et al. C-glycosides incorporating the 6-methoxy-2-naphthyl moiety are selective inhibitors of fungal and bacterial carbonic anhydrases. J Enzyme Inhib Med Chem 2014; Epub ahead of print
124. Sechi M, Innocenti A, Pala N, et al. Inhibition of alpha-class cytosolic human carbonic anhydrases I, II, IX and XII, and beta-class fungal enzymes by carboxylic acids and their derivatives: new isoform-I selective nanomolar inhibitors. Bioorg Med Chem Lett 2012;22:5801-6
125. Cottier F, Leewattanapasuk W, Kemp LR, et al. Carbonic anhydrase regulation and CO(2) sensing in the fungal pathogen Candida glabrata involves a novel Rca1p ortholog. Bioorg Med Chem 2013;21:1549-54
126. Rami M, Innocenti A, Montero JL, et al. Synthesis of rhodamine B-benzenesulfonamide conjugates and their inhibitory activity against human alpha- and bacterial/fungal beta-carbonic anhydrases. Bioorg Med Chem Lett 2011;21:5210-13
127. Carta F, Innocenti A, Hall RA, et al. Carbonic anhydrase inhibitors. Inhibition of the beta-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with branched aliphatic/aromatic carboxylates and their derivatives. Bioorg Med Chem Lett 2011;21:2521-6
128. Davis RA, Hofmann A, Osman A, et al. Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases. J Med Chem 2011;54:1682-92
129. Guzel O, Maresca A, Hall RA, et al. Carbonic anhydrase inhibitors. The betacarbonic anhydrases from the fungal pathogens Cryptococcus neoformans and Candida albicans are strongly inhibited by substituted-phenyl-1H-indole-5-sulfonamides. Bioorg Med Chem Lett 2010;20:2508-11
130. Innocenti A, Winum JY, Hall RA, et al. Carbonic anhydrase inhibitors. Inhibition of the fungal beta-carbonic anhydrases from Candida albicans and Cryptococcus neoformans with boronic acids. Bioorg Med Chem Lett 2009;19:2642-5
131. Innocenti A, Hall RA, Schlicker C, et al. Carbonic anhydrase inhibitors. Inhibition of the beta-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with aliphatic and aromatic carboxylates. Bioorg Med Chem 2009;17:2654-7
132. Innocenti A, Muhlschlegel FA, Hall RA, et al. Carbonic anhydrase inhibitors: inhibition of the beta-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with simple anions. Bioorg Med Chem Lett 2008;18:5066-70
133. Vullo D, Leewattanapasuk W, Muhlschlegel FA, et al. Carbonic anhydrase inhibitors: inhibition of the beta-class enzyme from the pathogenic yeast Candida glabrata with sulfonamides, sulfamates and sulfamides. Bioorg Med Chem Lett 2013;23:2647-52
134. Innocenti A, Leewattanapasuk W, Manole G, et al. Carbonic anhydrase activators: Activation of the beta-carbonic anhydrase from the pathogenic yeast Candida glabrata with amines and amino acids. Bioorg Med Chem Lett 2010;20:1701-4
135. Innocenti A, Leewattanapasuk W, Muhlschlegel FA, et al. Carbonic anhydrase inhibitors. Inhibition of the beta-class enzyme from the pathogenic yeast Candida glabrata with anions. Bioorg Med Chem Lett 2009;19:4802-5
136. Isik S, Kockar F, Aydin M, et al. Carbonic anhydrase activators: activation of the beta-carbonic anhydrase Nce103 from the yeast Saccharomyces cerevisiae with amines and amino acids. Bioorg Med Chem Lett 2009;19:1662-5
137. Isik S, Kockar F, Aydin M, et al. Carbonic anhydrase inhibitors: inhibition of the beta-class enzyme from the yeast Saccharomyces cerevisiae with sulfonamides and sulfamates. Bioorg Med Chem 2009;17:1158-63
138. Isik S, Kockar F, Arslan O, et al. Carbonic anhydrase inhibitors. Inhibition of the beta-class enzyme from the yeast Saccharomyces cerevisiae with anions. Bioorg Med Chem Lett 2008;18:6327-31
139. Carta F, Garaj V, Maresca A, et al. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies. Bioorg Med Chem 2011;19:3105-19
140. Schlicker C, Hall RA, Vullo D, et al. Structure and inhibition of the CO2-sensing carbonic anhydrase Can2 from the pathogenic fungus Cryptococcus neoformans. J Mol Biol 2009;385:1207-20
141. Hewitson KS, Vullo D, Scozzafava A, et al. Molecular cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Malassezia globosa, a potential antidandruff target. J Med Chem 2012;55:3513-20
142. Elleuche S, Poggeler S. Beta-carbonic anhydrases play a role in fruiting body development and ascospore germination in the filamentous fungus Sordaria macrospora. PLoS ONE 2009;4:e5177
143. Lehneck R, Elleuche S, Poggeler S. The filamentous ascomycete Sordaria macrospora can survive in ambient air without carbonic anhydrases. Mol Microbiol 2014;92:931-44
144. Lehneck R, Poggeler S. A matter of structure: structural comparison of fungal carbonic anhydrases. Appl Microbiol Biotechnol 2014;98:8433-41
145. Elleuche S, Poggeler S. Carbonic anhydrases in fungi. Microbiology 2010;156:23-9
146. Krungkrai J, Krungkrai SR, Supuran CT. Carbonic anhydrase inhibitors: inhibition of Plasmodium falciparum carbonic anhydrase with aromatic/heterocyclic sulfonamides-in vitro and in vivo studies. Bioorg Med Chem Lett 2008;18:5466-71
147. Krungkrai J, Scozzafava A, Reungprapavut S, et al. Carbonic anhydrase inhibitors. Inhibition of Plasmodium falciparum carbonic anhydrase with aromatic sulfonamides: towards antimalarials with a novel mechanism of action? Bioorg Med Chem 2005;13:483-9
148. Reungprapavut S, Krungkrai SR, Krungkrai J. Plasmodium falciparum carbonic anhydrase is a possible target for malaria chemotherapy. J Enzyme Inhib Med Chem 2004;19:249-56
149. Krungkrai SR, Suraveratum N, Rochanakij S, et al. Characterisation of carbonic anhydrase in Plasmodium falciparum. Int J Parasitol 2001;31:661-8
150. Vullo D, Del Prete S, Fisher GM, et al. Sulfonamide inhibition studies of the etaclass carbonic anhydrase from the malaria pathogen Plasmodium falciparum. Bioorg Med Chem 2015;23(3):526-31
151. Supuran CT, Capasso C. The eta-class carbonic anhydrases as drug targets for antimalarial agents. Expert Opin Ther Targets 2015;19(4):551-63
152. De Simone G, Supuran CT. (In)organic anions as carbonic anhydrase inhibitors. J Inorg Biochem 2012;111:117-29
153. Supuran CT, Di Fiore A, Alterio V, et al. Recent advances in structural studies of the carbonic anhydrase family: the crystal structure of human CA IX and CA XIII. Curr Pharm Des 2010;16:3246-54
154. De Simone G, Supuran CT. Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target. Biochim Biophys Acta 2010;1804:404-9
155. De Simone G, Di Fiore A, Supuran CT. Are carbonic anhydrase inhibitors suitable for obtaining antiobesity drugs? Curr Pharm Des 2008;14:655-60
156. Winum JY, Supuran CT. Recent advances in the discovery of zinc-binding motifs for the development of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2015;30(2):321-4
157. Pan P, Vermelho AB, Capaci Rodrigues G, et al. Cloning, characterization, and sulfonamide and thiol inhibition studies of an alphacarbonic anhydrase from Trypanosoma cruzi, the causative agent of Chagas disease. J Med Chem 2013;56:1761-71
158. Guzel-Akdemir O, Akdemir A, Pan P, et al. A class of sulfonamides with strong inhibitory action against the alphacarbonic anhydrase from Trypanosoma cruzi. J Med Chem 2013;56:5773-81
159. Von Stebut E. Leishmaniasis. J Dtsch Dermatol Ges 2015;13:191-201
160. Syrjanen L, Vermelho AB, Rodrigues Ide A, et al. Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Leishmania donovani chagasi, the protozoan parasite responsible for leishmaniasis. J Med Chem 2013;56:7372-81
161. Puscas I. Treatment of gastroduodenal ulcers with carbonic anhydrase inhibitors. Ann NY Acad Sci 1984;429:587-91
162. Modakh JK, Liu YC, Machuca MA, et al. Structural basis for the inhibition of Helicobacter pylori α-carbonic anhydrase by sulfonamides. PLoS One 2015;10:e0127149
163. Supuran CT, Clare BW. Carbonic anhydrase inhibitors-Part 57: Quantum chemical QSAR of a group of 1, 3, 4-thiadiazole- and 1, 3, 4-thiadiazoline disulfonamides with carbonic anhydrase inhibitory properties. Eur J Med Chem 1999;34:41-50
164. Briganti F, Pierattelli R, Supuran CT, et al. Carbonic anhydrase inhibitors. Part 37. Novel classes of isozyme I and II inhibitors and their mechanism of action. Kinetic and spectroscopic investigations on native and cobalt-substituted enzymes. Eur J Med Chem 1996;31:439-47
165. Vullo D, Del Prete S, Fisher GM, et al. Sulfonamide inhibition studies of the etaclass carbonic anhydrase from the malaria pathogen Plasmodium falciparum. Bioorg Med Chem 2015;23:526-31